The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
VEGF165 mediates glomerular endothelial repair
Open accessAbstract
VEGF(165), the most abundant isoform in man, is an angiogenic cytokine that also regulates vascular permeability. Its function in the renal glomerulus, where it is expressed in visceral epithelial and mesangial cells, is unknown. To assess the role of VEGF(165) in glomerular disease, we administered a novel antagonist - a high-affinity, nuclease-resistant RNA aptamer coupled to 40-kDa polyethylene glycol (PEG) - to normal rats and to rats with mesangioproliferative nephritis, passive Heymann nephritis (PHN), or puromycin aminonucleoside nephrosis (PAN). In normal rats, antagonism of VEGF(165) for 21 days failed to induce glomerular pathology or proteinuria. In rats with mesangioproliferative nephritis, the VEGF(165) aptamer (but not a sequence-scrambled control RNA or PEG alone) led to a reduction of glomerular endothelial regeneration and an increase in endothelial cell death, provoking an 8-fold increase in the frequency of glomerular microaneurysms by day 6. In contrast, early leukocyte influx and the proliferation, activation, and matrix accumulation of mesangial cells were not affected in these rats. In rats with PHN or PAN, administration of the VEGF(165) aptamer did not influence the course of proteinuria using various dosages and administration routes. These data identify VEGF(165) as a factor of central importance for endothelial cell survival and repair in glomerular disease, and point to a potentially novel way to influence the course of glomerular diseases characterized by endothelial cell damage, such as various glomerulonephritides, thrombotic microangiopathies, or renal transplant rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Gerber, H.-P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 1,981
Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., & Keshet, E. (1995) · Nature Medicine · doi:10.1038/nm1095-1024 · Cited by 1,604
The Emerging Concept of Vascular Remodeling
Epstein, F. H., Gibbons, G. H., & Dzau, V. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405193302008 · Cited by 1,575
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,365
Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,241
Breier, G., Albrecht, U., Sterrer, S., & Risau, W. (1992) · Development · doi:10.1242/dev.114.2.521 · Cited by 1,087
Roberts, W. G., & Palade, G. E. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2369 · Cited by 1,033
VEGF is required for growth and survival in neonatal mice
Gerber, H.-P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 915
Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1535 · Cited by 835
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Self-citationVascular endothelial growth factor and its receptors
Klagsbrun, M., & A. D'Amore, P. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00027-5 · Cited by 682
Carmeliet, P., Ng, Y.-S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., et al. (1999) · Nature Medicine · doi:10.1038/8379 · Cited by 679
The vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641
Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., & Senger, D. R. (1993) · PubMed · Cited by 564
Johnson, R. J., Iida, H., Alpers, C. E., Majesky, M. W., Schwartz, S. M., Pritzi, P., Gordon, K., & Gown, A. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115089 · Cited by 460
Jakeman, L. B., Winer, J., Bennett, G. L., Altar, C. A., & Ferrara, N. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115568 · Cited by 433
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues
Monacci, W. T., Merrill, M. J., & Oldfield, E. H. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.4.c995 · Cited by 370
Johnson, R. J., Raines, E. W., Floege, J., Yoshimura, A., Pritzl, P., Alpers, C., & Ross, R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1413 · Cited by 341
Self-citationBlood vessel maturation: vascular development comes of age
Darland, D. C., & D’Amore, P. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6127 · Cited by 335
Vascular permeability factor: A unique regulator of blood vessel function
Connolly, D. T. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470306 · Cited by 317
Iida, H., Seifert, R., Alpers, C. E., Gronwald, R. G., Phillips, P. E., Pritzl, P., Gordon, K., Gown, A. M., Ross, R., & Bowen-Pope, D. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6560 · Cited by 293
Simon, M., Grone, H. J., Johren, O., Kullmer, J., Plate, K. H., Risau, W., & Fuchs, E. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.2.f240 · Cited by 288
Vascular permeability factor mRNA and protein expression in human kidney
Brown, L. F., Berse, B., Tognazzi, K., Manseau, E. J., Van De Water, L., Senger, D. R., Dvorak, H. F., & Rosen, S. (1992) · Kidney International · doi:10.1038/ki.1992.441 · Cited by 267
Increased synthesis of extracellular matrix in mesangial proliferative nephritis
Floege, J., Johnson, R. J., Gordon, K., Iida, H., Pritzl, P., Yoshimura, A., Campbell, C., Alpers, C. E., & Couser, W. G. (1991) · Kidney International · doi:10.1038/ki.1991.235 · Cited by 264
Self-citationMonoclonal Antibody to Single-Stranded DNA Is a Specific and Sensitive Cellular Marker of Apoptosis
Frankfurt, O. S., Robb, J. A., Sugarbaker, E. V., & Villa, L. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0240 · Cited by 244
Novel Approach to Specific Growth Factor Inhibition in Vivo
Floege, J., Ostendorf, T., Janssen, U., Burg, M., Radeke, H. H., Vargeese, C., Gill, S. C., Green, L. S., & Janjic, N. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65263-7 · Cited by 233
Self-citationCell renewal of glomerular cell types in normal rats. An autoradiographic analysis
Pabst, R., & Sterzel, R. B. (1983) · Kidney International · doi:10.1038/ki.1983.203 · Cited by 228
Quantitative and qualitative studies of antibody–induced mesangial cell damage in the rat
Yamamoto, T., & Wilson, C. B. (1987) · Kidney International · doi:10.1038/ki.1987.240 · Cited by 203
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.
Lee, L. K., Meyer, T. W., Pollock, A. S., & Lovett, D. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118143 · Cited by 197
Johnson, R. J., Garcia, R. L., Pritzl, P., & Alpers, C. E. (1990) · PubMed Central · Cited by 191
Vascular endothelial growth factor and its receptors
Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T., & Levi, B.-Z. (1994) · Progress in Growth Factor Research · doi:10.1016/0955-2235(94)90019-1 · Cited by 190
Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.
Shulman, K., Rosen, S., Tognazzi, K., Manseau, E. J., & Brown, L. F. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v75661 · Cited by 183
Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
Iruela‐Arispe, M. L., GORDON, K. L., Hugo, C., Duijvestijn, A. M., Claffey, K. P., Reilly, M. T., Couser, W. G., Alpers, C. E., & Johnson, R. J. (1995) · Europe PMC (PubMed Central) · Cited by 178
Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor
Iijima, K., Yoshikawa, N., Connolly, D. T., & Nakamura, H. (1993) · Kidney International · doi:10.1038/ki.1993.337 · Cited by 164
Expression of vascular endothelial growth factor in renal vascular disease and renal allografts
Gröne, H., Simon, M., & Gröne, E. F. (1995) · The Journal of Pathology · doi:10.1002/path.1711770308 · Cited by 124
Gruden, G., Thomas, S., Burt, D. J., Lane, S. J., Chusney, G. D., Sacks, S. H., & Viberti, G. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12112 · Cited by 121
Yoshimura, A., Gordon, K., Alpers, C. E., Floege, J., Pritzl, P., Ross, R., Couser, W. G., Bowen‐Pope, D. F., & Johnson, R. J. (1991) · Kidney International · doi:10.1038/ki.1991.234 · Cited by 110
Self-citationOligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro
Bell, C., Lynam, E. B., Landfair, D. J., Janjić, N., & Wiles, M. E. (1999) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-999-0064-y · Cited by 109
Intraglomerular platelet aggregation and experimental glomerulonephritis
Poelstra, K., Hardonk, M. J., Koudstaal, J., & Bakker, W. W. (1990) · Kidney International · doi:10.1038/ki.1990.141 · Cited by 84
Renal microvascular assembly and repair: Power and promise of molecular definition
Takahashi, T., Huynh‐Do, U., & Daniel, T. O. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00822.x · Cited by 70
Schröppel, B., Huber, S. M., Horster, M. F., Schlöndorff, D., & Kretzler, M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00742.x · Cited by 30
Activation of Flk-1/KDR mediates angiogenesis but not hypotension
Malavaud, B. A. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00177-6 · Cited by 27
Cited by
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,313
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Metadata
- Authors
- Ostendorf, T., Kunter, U., Eitner, F., Loos, A., Regele, H., Kerjaschki, D., Henninger, D. D., Janjic, N., & Floege, J.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-10-01
- Volume
- 104
- Issue
- 7
- Pages
- 913-923
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2167528781
- Cited by
- 287
- References
- 44
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.